Furthermore, pharmacological inhibition of USP10 using Spautin-1 synergizes with cisplatin to enhance anti-tumor efficacy, suggesting a potential therapeutic strategy for overcoming chemoresistance. The gene discussed is USP10; the disease is neoplasm.